Announcement under Regulation 30 (LODR)-Newspaper Publication
Filed with BSE · · 3 pages · English
Sandu Pharmaceuticals Limited on 6ix
Earlier from Sandu Pharmaceuticals
- Board Meeting Intimation for Approval Of Unaudited Financials For Quarter And Half Year Ended 30Th September 2026
- Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.
- Sandu Pharmaceuticals Limited Press Release Sep 30 2026
- Intimation To The Holders Of Physical Securities To Furnish PAN And KYC Details
- Sandu Pharmaceuticals Limited Press Release Sep 04 2026
Follow Sandu Pharmaceuticals into a list and get an email when it puts out news.
Follow Sandu Pharmaceuticals